Morepen Laboratories Ltd share price logo

Morepen Laboratories Share Price

(MOREPENLAB)

₹52.41▲0.77%

as on 04:01PM, 20 Feb 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Morepen Laboratories Performance

  • Day's Low

    Day's High

    ₹51.15
    Day's Price Range
    ₹52.92

  • 52 Week's Low

    52 Week's High

    ₹38.55
    52-Week Price Range
    ₹100.9
1 Month Return-26.67 %
3 Month Return-28.98 %
1 Year Return-3.86 %
Previous Close₹52.01
Open₹52.00
Volume24.51L
Upper Circuit-
Lower Circuit-
Market Cap₹2,849.91Cr

Morepen Laboratories Key Statistics

P/E Ratio

21.76

PEG Ratio

24.45

Market Cap

₹2,849.91 Cr

P/B Ratio

2.42

EPS

1.89

Dividend Yield

0

Sector

Pharmaceuticals

ROE

13.29

Morepen Laboratories Mutual Fund Holdings

Key events for Morepen Laboratories Ltd

  • Morepen Laboratories Launches Online Pharmacy Subsidiary - 19 Feb, 2025

    Morepen Laboratories is venturing into the online retail pharmacy sector by forming Quick Med Private Limited, a step-down subsidiary, to capitalize on growing digital healthcare demand.

  • Morepen Labs Shares Plummet Amid Heavy Trading - 10 Feb, 2025

    Morepen Laboratories Ltd experienced significant stock declines, with shares falling 18% due to heavy trading volumes and mixed financial results for Q3FY25. The stock settled over 4% lower by the end of the day.

  • Morepen Lab Reports Mixed Financial Results - 07 Feb, 2025

    Morepen Laboratories reported a 1.85% increase in net sales to Rs 452.78 crore for December 2024. However, net profit fell 16.57% to Rs 26.69 crore, and EBITDA decreased by 24.08%. The EPS also declined from Rs 0.63 to Rs 0.49. Despite these challenges, shares closed at Rs 62.68, reflecting a 9.62% return over the last six months.

Insights on Morepen Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.08% to 2.22% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 442.71 Cr → 458.12 Cr (in ₹), with an average increase of 3.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 59.9% return, outperforming this stock by 63.7%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 135.1% return, outperforming this stock by 107.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 35.65% of holdings in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 60.56% to 60.47% in Dec 2024 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, MOREPENLAB stock has moved down by -26.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 3 quarters, 36.17 Cr → 26.69 Cr (in ₹), with an average decrease of 13.5% per quarter

Morepen Laboratories Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹444.55Cr (-)₹423.07Cr (↓4.83%)₹455.22Cr (↑7.60%)₹437.73Cr (↓3.84%)₹452.78Cr (↑3.44%)
Net Income₹31.99Cr (-)₹28.74Cr (↓10.16%)₹36.17Cr (↑25.85%)₹34.85Cr (↓3.65%)₹26.69Cr (↓23.41%)
Net Profit Margin7.20% (-)6.79% (↓5.69%)7.95% (↑17.08%)7.96% (↑0.13%)5.89% (↓26.01%)
Value in ₹ crore
Details2021202220232024
Total Assets₹847.51Cr (-)₹1,042.45Cr (↑23.00%)₹1,115.11Cr (↑6.97%)₹1,289.69Cr (↑15.66%)
Total Liabilities₹402.54Cr (-)₹444.28Cr (↑10.37%)₹334.99Cr (↓24.60%)₹400.66Cr (↑19.60%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow₹10.86Cr (-)₹49.31Cr (↑354.05%)-₹68.87Cr (↓239.67%)-₹102.12Cr (↑48.28%)₹77.36Cr (↓175.75%)

Index Inclusions

BSE Healthcare

₹40,263.69

0.4 (▲159.55%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

BSE Small-Cap

₹46,054.94

1.32 (▲599.11%)

Morepen Laboratories Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
35.65%
0.00
Foreign Institutions
2.22%
6.96
Mutual Funds
0%
33.33
Retail Investors
60.47%
-0.15
Others
1.65%
-3.25

Morepen Laboratories Key Indicators

Details20202021202220232024
Earning Per Share (₹)0.752.162.130.761.89
Details20202021202220232024
Return On Equity %9.8624.4319.386.7113.29
Details20202021202220232024
Return On Assets %5.0711.469.753.477.46
Details20202021202220232024
Book Value Per Share (₹)6.328.4711.5614.7316.58

Morepen Laboratories Valuation

Morepen Laboratories in the last 5 years

  • Overview

  • Trends

Lowest (10.48x)

March 23, 2020

Today (21.76x)

February 19, 2025

Industry (51.87x)

February 19, 2025

Highest (64.70x)

January 22, 2018

LowHigh

Morepen Laboratories Earnings and Dividends

  • Morepen Laboratories Ltd Earnings Results

    Morepen Laboratories Ltd’s net profit fell -16.57% since last year same period to ₹26.69Cr in the Q3 2024-2025. On a quarterly growth basis, Morepen Laboratories Ltd has generated -23.41% fall in its net profits since last 3-months.

    Read More about Earnings Results

Morepen Laboratories Technicals Summary

Bearish

Neutral

Bullish

Bearish

Morepen Laboratories Ltd is currently in a Bearish trading position according to technical analysis indicators.

More on Technical Analysis

Morepen Laboratories Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Morepen Laboratories Ltd
Morepen Laboratories Ltd
NA₹2,849.91 Cr53.51%0.53₹96 Cr₹1,690 Cr
Bharat Immunological & Biological Corporation Ltd
Bharat Immunological & Biological Corporation Ltd
NA₹102.38 Cr43.14%0.73NANA
Natco Pharma Ltd
Natco Pharma Ltd
HOLD₹14,561.63 Cr4.54%0.54₹1,388 Cr₹3,998 Cr
Akums Drugs & Pharmaceuticals Ltd
Akums Drugs & Pharmaceuticals Ltd
BUY₹7,790.22 Cr-7.57%0.00₹97 Cr₹4,178 Cr
Titan Biotech Ltd
Titan Biotech Ltd
NA₹368.31 Cr191.73%0.54₹23 Cr₹164 Cr
See all

About Morepen Laboratories

Morepen Laboratories Limited is a pharmaceutical company based in India that develops and markets formulation products in numerous therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic, and neuropsychiatry. Their products include Loratadine Montelukast Sodium, Atorvastatin Calcium and Sultamicillin, along with new entries such as Kilbac Ducal, D Aclomore and Montelast-L. It currently has three state-of-the-art manufacturing plants in Himachal Pradesh, India, with the main plant in Parwanoo being USFDA-approved for Loratadine production. The company was established in 1984 and since then has filed 14 patents, including an international one on a new amorphous form of Lipitor Atorvastatin. Expansion plans from 1992-1993 saw the installation of bulk drugs from 162 MT to 245 MT and the launch of two new molecules – Ketrolac, Tromethamine and Omeprazole. In 1995-1996, the company increased bulk drug installation from 305 MT to 469 MT and launched Loratadine and Cisapride. The year 1996-1997 saw the commencement of their own formulation unit, while they filed an international patent on a new amorphous form of Atorvastatin, world’s largest selling drug in 2000-2001. In 2001-2002, their drug and drug intermediate installation reached 1251 MT, with the launch of a number of contemporary lifestyle and self-medication products. Their joint venture with DiaMed AG of Switzerland was among the highlights of the year 2004-2005, while 2006-2007 saw them acquire fifty new prospective customers in Korea, Japan and Taiwan. The year 2007-2008 was marked by the company making tie-ups with several new business segments, along with marketing alliances with global players such as Immucor USA, Teco Medical Instruments, and In-Tech, INC.

Share Price: ₹52.41 per share as on 20 Feb, 2025 04:01 PM
Market Capitalisation: ₹2,849.91Cr as of today
Revenue: ₹452.78Cr as on December 2024 (Q4 24)
Net Profit: ₹26.69Cr as on December 2024 (Q4 24)
Listing date: 15 May, 1995
Chairperson Name: Sushil Suri
OrganisationMorepen Laboratories
HeadquartersGurgaon
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Morepen Laboratories Ltd

What is Morepen Laboratories Ltd price today?

Morepen Laboratories Ltd share price today stands at ₹52.41, Open: ₹52, Previous Close: ₹52.01, High: ₹52.92, Low: ₹51.15, 52 Week High: ₹100.9, 52 Week Low: ₹38.55.

How to Buy Morepen Laboratories Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Morepen Laboratories Ltd shares

Is Morepen Laboratories Ltd listed on NSE?

Morepen Laboratories Ltd is listed on NSE

Is Morepen Laboratories Ltd listed on BSE?

Morepen Laboratories Ltd is listed on BSE

What are today's High and Low prices of Morepen Laboratories Ltd?

  • Today's highest price of Morepen Laboratories Ltd is ₹52.92.
  • Today's lowest price of Morepen Laboratories Ltd is ₹51.15.

What are today's traded volumes of Morepen Laboratories Ltd?

Today's traded volume of Morepen Laboratories Ltd(MOREPENLAB) is 24.51L.

What is today's market capitalisation of Morepen Laboratories Ltd?

Today's market capitalisation of Morepen Laboratories Ltd(MOREPENLAB) is ₹2849.91Cr.

What is the 52 Week High and Low Range of Morepen Laboratories Ltd?

Morepen Laboratories Ltd (MOREPENLAB)
Price
52 Week High
₹100.9
52 Week Low
₹38.55

How much percentage Morepen Laboratories Ltd is down from its 52 Week High?

Morepen Laboratories Ltd (MOREPENLAB) share price is ₹52.41. It is down -48.06% from its 52 Week High price of ₹100.9

How much percentage Morepen Laboratories Ltd is up from its 52 Week low?

Morepen Laboratories Ltd (MOREPENLAB) share price is ₹52.41. It is up 35.95% from its 52 Week Low price of ₹38.55

What are the historical returns of Morepen Laboratories Ltd?

Morepen Laboratories Ltd (MOREPENLAB)
Returns
1 Day Returns
0.4%
1 Month Returns
-26.67%
3 Month Returns
-28.98%
1 Year Returns
-3.86%

What is the PE ratio of Morepen Laboratories Ltd today?

PE Ratio of Morepen Laboratories Ltd is 21.76

PE ratio = Morepen Laboratories Ltd Market price per share / Morepen Laboratories Ltd Earnings per share